Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,640 | 400 | 460 | 380 | 350 |
| Marketable Securities | 0 | 250 | 750 | 1,600 | 400 |
| Receivables | 70 | 0 | 0 | 70 | 0 |
| Other current assets | 60 | 110 | 100 | 60 | 140 |
| TOTAL | $1,770 | $760 | $1,310 | $2,110 | $890 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,027 | 2,547 | 2,487 | 2,477 | 2,347 |
| TOTAL | $3,027 | $2,547 | $2,487 | $2,477 | $2,347 |
| Total Assets | $4,810 | $3,320 | $3,810 | $4,610 | $3,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 300 | 100 | 80 | 130 | 100 |
| Accrued Expenses | 500 | 370 | 230 | 240 | 540 |
| Other current liabilities | 10 | 10 | 20 | 20 | 30 |
| TOTAL | $820 | $500 | $340 | $400 | $680 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 130 | 120 | 130 | 130 | 130 |
| TOTAL | $130 | $120 | $130 | $130 | $130 |
| Total Liabilities | $960 | $630 | $470 | $530 | $810 |
| Shareholders' Equity | |||||
| Common Shares | 170 | 170 | 170 | 170 | 150 |
| Retained earnings | -26,000 | -25,620 | -24,900 | -24,100 | -22,970 |
| Other shareholders' equity | 0 | 10 | 0 | 0 | 0 |
| TOTAL | $3,850 | $2,690 | $3,340 | $4,080 | $2,430 |
| Total Liabilities And Equity | $4,810 | $3,320 | $3,810 | $4,610 | $3,240 |